{"id":302,"date":"2022-01-18T18:58:50","date_gmt":"2022-01-18T18:58:50","guid":{"rendered":"https:\/\/revisamed.com.br\/blog-wp-teste\/2022\/01\/18\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/"},"modified":"2023-05-11T18:28:56","modified_gmt":"2023-05-11T18:28:56","slug":"classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais","status":"publish","type":"post","link":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/","title":{"rendered":"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais!"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" loading=\"lazy\" width=\"1024\" height=\"682\" src=\"https:\/\/revisamed.com.br\/blog\/wp-content\/uploads\/2022\/01\/c272680321343cd7-cancer-prostata-1024x682-1.jpg\" alt=\"Aproximadamente 15% dos pacientes com c\u00e2ncer de pr\u00f3stata s\u00e3o diagnosticados com doen\u00e7a de alto risco.\" class=\"wp-image-16404\"><\/figure>\n<\/div>\n<p>Resumo: Aproximadamente 15% dos pacientes com c\u00e2ncer de pr\u00f3stata s\u00e3o diagnosticados com doen\u00e7a de alto risco. No entanto, as defini\u00e7\u00f5es atuais de c\u00e2ncer de pr\u00f3stata de alto risco incluem um grupo heterog\u00eaneo de pacientes com uma variedade de progn\u00f3sticos. Alguns t\u00eam o potencial de progredir para um fen\u00f3tipo letal que pode ser fatal, enquanto outros podem ser curados apenas com o tratamento do tumor prim\u00e1rio. O manejo ideal deste subgrupo de pacientes est\u00e1 evoluindo. Um esquema de classifica\u00e7\u00e3o refinado \u00e9 necess\u00e1rio para permitir a identifica\u00e7\u00e3o precoce e precisa de doen\u00e7as de alto risco para que paradigmas de tratamento mais eficazes possam ser desenvolvidos. Discutimos v\u00e1rios princ\u00edpios estabelecidos a partir de ensaios cl\u00ednicos e destacamos outras quest\u00f5es que permanecem sem resposta. Esta revis\u00e3o avalia criticamente a literatura existente com foco na defini\u00e7\u00e3o da popula\u00e7\u00e3o de alto risco,<\/p>\n<p>Chang AJ, Autio KA, Roach M 3rd, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014 Jun;11(6):308-23.<\/p>\n<p>Leia o artigo na \u00edntegra: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24840073\/\" target=\"_blank\" rel=\"noopener noreferrer\">clique aqui<\/a>.<\/p>\n<p>Voc\u00ea tamb\u00e9m pode se interessar por <a href=\"https:\/\/revisamed.com.br\/blog\/cancer-de-prostata-e-tema-de-artigo-do-medicina-atual\/\" target=\"_blank\" rel=\"noopener noreferrer\">C\u00e2ncer de Pr\u00f3stata \u00e9 tema de artigo do Medicina Atual<\/a>.<\/p>\n<nav class=\"post-tags\" aria-label=\"Tags do conte\u00fado\"><a href=\"\/tag\/especialidades-medicas\/\">especialidades m\u00e9dicas<\/a><a href=\"\/tag\/oncologia\/\">Oncologia<\/a><a href=\"\/tag\/urologia\/\">Urologia<\/a><\/nav>\n","protected":false},"excerpt":{"rendered":"<p>Aproximadamente 15% dos pacientes com c\u00e2ncer de pr\u00f3stata s\u00e3o diagnosticados com doen\u00e7a de alto risco. Entenda o assunto.<\/p>\n","protected":false},"author":2,"featured_media":303,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[24,50,52],"rvm_specialty":[],"class_list":["post-302","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-especialidades-medicas","tag-oncologia","tag-urologia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.7 (Yoast SEO v28.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais! | Blog Revisamed<\/title>\n<meta name=\"description\" content=\"Aproximadamente 15% dos pacientes com c\u00e2ncer de pr\u00f3stata s\u00e3o diagnosticados com doen\u00e7a de alto risco. Entenda o assunto.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais!\" \/>\n<meta property=\"og:description\" content=\"Aproximadamente 15% dos pacientes com c\u00e2ncer de pr\u00f3stata s\u00e3o diagnosticados com doen\u00e7a de alto risco. Entenda o assunto.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog Revisamed\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/revisamedmedprovas\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-18T18:58:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-11T18:28:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/revisamed.com.br\/blog\/wp-content\/uploads\/2022\/01\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg\" \/>\n<meta name=\"author\" content=\"Revisamed\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Revisamed\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/\"},\"author\":{\"name\":\"Revisamed\",\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/#\\\/schema\\\/person\\\/039ecb0a2b1b90b5e041ad669bbcecc4\"},\"headline\":\"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais!\",\"datePublished\":\"2022-01-18T18:58:50+00:00\",\"dateModified\":\"2023-05-11T18:28:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/\"},\"wordCount\":222,\"publisher\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg\",\"keywords\":[\"especialidades m\u00e9dicas\",\"Oncologia\",\"Urologia\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/\",\"url\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/\",\"name\":\"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais! | Blog Revisamed\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg\",\"datePublished\":\"2022-01-18T18:58:50+00:00\",\"dateModified\":\"2023-05-11T18:28:56+00:00\",\"description\":\"Aproximadamente 15% dos pacientes com c\u00e2ncer de pr\u00f3stata s\u00e3o diagnosticados com doen\u00e7a de alto risco. Entenda o assunto.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/#primaryimage\",\"url\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg\",\"contentUrl\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/\",\"name\":\"Blog Revisamed\",\"description\":\"Not\u00edcias, editais de resid\u00eancia m\u00e9dica e conte\u00fados para estudar medicina.\",\"publisher\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/#organization\",\"name\":\"Blog Revisamed\",\"url\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/revisamed-light-scaled.png\",\"contentUrl\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/revisamed-light-scaled.png\",\"width\":2560,\"height\":548,\"caption\":\"Blog Revisamed\"},\"image\":{\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/revisamedmedprovas\",\"https:\\\/\\\/www.instagram.com\\\/revisamed__medprovas\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@gruporevisamed_medprovas\"]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/#\\\/schema\\\/person\\\/039ecb0a2b1b90b5e041ad669bbcecc4\",\"name\":\"Revisamed\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"Revisamed\"},\"url\":\"https:\\\/\\\/revisamed.com.br\\\/blog\\\/autor\\\/claudia\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais! | Blog Revisamed","description":"Aproximadamente 15% dos pacientes com c\u00e2ncer de pr\u00f3stata s\u00e3o diagnosticados com doen\u00e7a de alto risco. Entenda o assunto.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/","og_locale":"pt_BR","og_type":"article","og_title":"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais!","og_description":"Aproximadamente 15% dos pacientes com c\u00e2ncer de pr\u00f3stata s\u00e3o diagnosticados com doen\u00e7a de alto risco. Entenda o assunto.","og_url":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/","og_site_name":"Blog Revisamed","article_publisher":"https:\/\/www.facebook.com\/revisamedmedprovas","article_published_time":"2022-01-18T18:58:50+00:00","article_modified_time":"2023-05-11T18:28:56+00:00","og_image":[{"url":"https:\/\/revisamed.com.br\/blog\/wp-content\/uploads\/2022\/01\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg","type":"","width":"","height":""}],"author":"Revisamed","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Revisamed","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/#article","isPartOf":{"@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/"},"author":{"name":"Revisamed","@id":"https:\/\/revisamed.com.br\/blog\/#\/schema\/person\/039ecb0a2b1b90b5e041ad669bbcecc4"},"headline":"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais!","datePublished":"2022-01-18T18:58:50+00:00","dateModified":"2023-05-11T18:28:56+00:00","mainEntityOfPage":{"@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/"},"wordCount":222,"publisher":{"@id":"https:\/\/revisamed.com.br\/blog\/#organization"},"image":{"@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/#primaryimage"},"thumbnailUrl":"https:\/\/revisamed.com.br\/blog\/wp-content\/uploads\/2022\/01\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg","keywords":["especialidades m\u00e9dicas","Oncologia","Urologia"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/","url":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/","name":"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais! | Blog Revisamed","isPartOf":{"@id":"https:\/\/revisamed.com.br\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/#primaryimage"},"image":{"@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/#primaryimage"},"thumbnailUrl":"https:\/\/revisamed.com.br\/blog\/wp-content\/uploads\/2022\/01\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg","datePublished":"2022-01-18T18:58:50+00:00","dateModified":"2023-05-11T18:28:56+00:00","description":"Aproximadamente 15% dos pacientes com c\u00e2ncer de pr\u00f3stata s\u00e3o diagnosticados com doen\u00e7a de alto risco. Entenda o assunto.","breadcrumb":{"@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/#primaryimage","url":"https:\/\/revisamed.com.br\/blog\/wp-content\/uploads\/2022\/01\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg","contentUrl":"https:\/\/revisamed.com.br\/blog\/wp-content\/uploads\/2022\/01\/a657f4e9ab9b4a8c-cancer-prostata-1024x682-2.jpg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/revisamed.com.br\/blog\/classificacao-e-terapia-do-cancer-de-prostata-de-alto-risco-saiba-mais\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/revisamed.com.br\/blog\/"},{"@type":"ListItem","position":2,"name":"Classifica\u00e7\u00e3o e terapia do c\u00e2ncer de pr\u00f3stata de alto risco: saiba mais!"}]},{"@type":"WebSite","@id":"https:\/\/revisamed.com.br\/blog\/#website","url":"https:\/\/revisamed.com.br\/blog\/","name":"Blog Revisamed","description":"Not\u00edcias, editais de resid\u00eancia m\u00e9dica e conte\u00fados para estudar medicina.","publisher":{"@id":"https:\/\/revisamed.com.br\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/revisamed.com.br\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/revisamed.com.br\/blog\/#organization","name":"Blog Revisamed","url":"https:\/\/revisamed.com.br\/blog\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/revisamed.com.br\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/revisamed.com.br\/blog\/wp-content\/uploads\/2026\/10\/revisamed-light-scaled.png","contentUrl":"https:\/\/revisamed.com.br\/blog\/wp-content\/uploads\/2026\/10\/revisamed-light-scaled.png","width":2560,"height":548,"caption":"Blog Revisamed"},"image":{"@id":"https:\/\/revisamed.com.br\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/revisamedmedprovas","https:\/\/www.instagram.com\/revisamed__medprovas\/","https:\/\/www.youtube.com\/@gruporevisamed_medprovas"]},{"@type":"Organization","@id":"https:\/\/revisamed.com.br\/blog\/#\/schema\/person\/039ecb0a2b1b90b5e041ad669bbcecc4","name":"Revisamed","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"Revisamed"},"url":"https:\/\/revisamed.com.br\/blog\/autor\/claudia\/"}]}},"_links":{"self":[{"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/posts\/302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/comments?post=302"}],"version-history":[{"count":1,"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/posts\/302\/revisions"}],"predecessor-version":[{"id":305,"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/posts\/302\/revisions\/305"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/media\/303"}],"wp:attachment":[{"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/media?parent=302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/categories?post=302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/tags?post=302"},{"taxonomy":"rvm_specialty","embeddable":true,"href":"https:\/\/revisamed.com.br\/blog\/wp-json\/wp\/v2\/rvm_specialty?post=302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}